Weiss Asset Management’s Meridian Bioscience Inc VIVO Stock Holding History

Weiss Asset Management’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-20,200	Closed	-$671K	–	667
2022 Q4	$671K	Hold	20,200	–	–	0.03%	333
2022 Q3	$637K	Buy	+20,200	New	+$654K	0.02%	507
2019 Q4	–	Sell	-13,100	Closed	-$124K	–	404
2019 Q3	$124K	Buy	+13,100	New	+$138K	0.01%	316

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Weiss Asset Management's VIVO Position: Q1 2023 in Review

Weiss Asset Management sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 20,200 shares — an estimated $671K sold.

Weiss Asset Management first reported a position in VIVO in Q3 2019 and held it in 3 quarters. The position peaked at $671K in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Weiss Asset Management reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Weiss Asset Management sold 20,200 Meridian Bioscience Inc shares in Q1 2023, an estimated $671K.
Weiss Asset Management first reported a position in Meridian Bioscience Inc in Q3 2019 and held it in 3 quarters.
Weiss Asset Management's Meridian Bioscience Inc position peaked at $671K in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Weiss Asset Management's 13F filing for Q1 2023, filed 10 May 2023.